D. Robertson, M. Goldberg, A. Hollister, J. Onrot, R. Wiley et al., Isolated Failure of Autonomic Noradrenergic Neurotransmission, New England Journal of Medicine, vol.314, issue.23, pp.1494-1497, 1986.
DOI : 10.1056/NEJM198606053142307

S. Thomas, A. Matsumoto, and R. Palmiter, Noradrenaline is essential for mouse fetal development, Nature, vol.374, issue.6523, pp.643-646, 1995.
DOI : 10.1038/374643a0

J. Deinum, G. Steengergen-spanjers, M. Jansen, F. Boomsma, J. Lenders et al., DBH gene variants that cause low plasma dopamine ??? hydroxylase with or without a severe orthostatic syndrome, Journal of Medical Genetics, vol.41, issue.4, p.38, 2004.
DOI : 10.1136/jmg.2003.009282

A. Lamouroux, A. Vigny, F. Biguet, N. Darmon, M. Franck et al., The primary structure of human dopaminebeta-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme, EMBO J National Center for Biotechnology Information, vol.6, issue.5, pp.3931-3937, 1987.

C. Zabetian, R. Romero, D. Robertson, S. Sharma, J. Padbury et al., A revised allele frequency estimate and haplotype analysis of the DBH deficiency mutation IVS1+2T?????????C in African- and European-Americans, American Journal of Medical Genetics Part A, vol.68, issue.2
DOI : 10.1002/ajmg.a.20300

J. Cubells and C. Zabetian, Human genetics of plasma dopamine ?hydroxylase activity: applications to research in psychiatry and neurology, Psychopharmacology, vol.174, pp.463-476, 2004.

J. Cryan, O. Leary, O. Jin, S. Friedland, J. Ouyang et al., Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors, Proceedings of the National Academy of Sciences, vol.28, issue.3, pp.8186-8191, 2004.
DOI : 10.1017/S0033291798006710

F. Axelrod, Familial dysautonomia, Muscle & Nerve, vol.294, issue.3, pp.352-363, 2004.
DOI : 10.1002/mus.10499
URL : https://hal.archives-ouvertes.fr/hal-00701177

S. Kaler, Metabolic and molecular bases of Menkes disease and occipital horn syndrome, Pediatr Dev Pathol, vol.1, pp.85-98, 1998.

R. Weinshilboum, H. Schorott, F. Raymond, W. Weidman, and L. Elveback, Inheritance of very low serum dopamine-betahydroxylase activity, Am J Hum Genet, vol.27, pp.573-585, 1975.

D. Robertson, V. Haile, and S. Perry, Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation, Hypertension, vol.18, issue.1, pp.1-8, 1991.
DOI : 10.1161/01.HYP.18.1.1

R. Freeman and L. Landsberg, The Treatment of Orthostatic Hypotension With Dihydroxyphenylserine, Clinical Neuropharmacology, vol.14, issue.4, pp.296-304, 1991.
DOI : 10.1097/00002826-199108000-00002

S. Thomas, B. Marck, R. Palmiter, and A. Matsumoto, Restoration of Norepinephrine and Reversal of Phenotypes in Mice Lacking Dopamine ??-Hydroxylase, Journal of Neurochemistry, vol.70, issue.6, pp.2468-2476, 1998.
DOI : 10.1046/j.1471-4159.1998.70062468.x

I. Biaggioni and D. Robertson, ENDOGENOUS RESTORATION OF NORADRENALINE BY PRECURSOR THERAPY IN DOPAMINE-BETA-HYDROXYLASE DEFICIENCY, The Lancet, vol.330, issue.8569, pp.1170-1172, 1987.
DOI : 10.1016/S0140-6736(87)91317-1